Advanced search
Publication Cover
Vascular Health and Risk Management Volume 10, 2014 - Issue
Submit an article Journal homepage
60
Views
9
CrossRef citations to date
0
Altmetric
Short Report

Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes

Matthias Blüher1 Department of Medicine, University of Leipzig, Leipzig, GermanyCorrespondence[email protected]
,
Anja Schweizer2 Novartis Pharma AG, Basel, Switzerland
,
Giovanni Bader2 Novartis Pharma AG, Basel, Switzerland
&
James E Foley3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Pages 661-664 | Published online: 20 Nov 2014

Figures & data

Figure 1 Change in weight as a function of baseline FPG in patients with type 2 diabetes mellitus after 24 weeks of treatment with vildagliptin.

Abbreviation: FPG, fasting plasma glucose.
Figure 1 Change in weight as a function of baseline FPG in patients with type 2 diabetes mellitus after 24 weeks of treatment with vildagliptin.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.